• Issue

    Pharmacoepidemiology and Drug Safety: Volume 20, Issue 11

    1115-1223
    November 2011
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Original Reports

Measuring balance and model selection in propensity score methods

Svetlana V. Belitser,  Edwin P. Martens,  Wiebe R. Pestman,  Rolf H.H. Groenwold,  Anthonius de Boer,  Olaf H. Klungel, 
  • Pages: 1115-1129
  • First Published: 29 July 2011

Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction

Rolf H. H. Groenwold,  Frank de Vries,  Anthonius de Boer,  Wiebe R. Pestman,  Frans H. Rutten,  Arno W. Hoes,  Olaf H. Klungel, 
  • Pages: 1130-1137
  • First Published: 23 September 2011

Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease

Michelle R. Denburg,  Kevin Haynes,  Justine Shults,  James D. Lewis,  Mary B. Leonard, 
  • Pages: 1138-1149
  • First Published: 24 August 2011

Validation of ICD-9-CM codes to identify gastrointestinal perforation events in administrative claims data among hospitalized rheumatoid arthritis patients

Jeffrey R. Curtis,  Shih-Yin Chen,  Winifred Werther,  Ani John,  David A. Johnson, 
  • Pages: 1150-1158
  • First Published: 27 August 2011

Identification of esophageal cancer in the General Practice Research Database

Alexander M. Walker, 
  • Pages: 1159-1167
  • First Published: 16 September 2011

Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy

Susan E. Andrade,  Tiffany A. Moore Simas,  Denise Boudreau,  Marsha A. Raebel,  Sengwee Toh,  Beth Syat,  Inna Dashevsky,  Richard Platt, 
  • Pages: 1168-1176
  • First Published: 22 August 2011

Discrepancies between the electronic medical record, the prescriptions in the Swedish national prescription repository and the current medication reported by patients

Anders Ekedahl,  Helen Brosius,  Julia Jönsson,  Hanna Karlsson,  Maria Yngvesson, 
  • Pages: 1177-1183
  • First Published: 22 August 2011

Impact of exposure accrual on sequential postmarket evaluations: a simulation study

Judith C. Maro,  Jeffrey S. Brown, 
  • Pages: 1184-1191
  • First Published: 24 August 2011

Methodological challenges in the coding and adjudication of sudden deaths in a large simple trial with observational follow-up: the ziprasidone observational study of cardiac outcomes (ZODIAC)

Jamie L. Geier,  Onur N. Karayal,  Michael Lewis,  John A. Camm,  Martin Keane,  Charlotte ME. Kremer,  Sheela Kolluri,  Robert Reynolds,  Sybil Eng,  Brian L. Strom, 
  • Pages: 1192-1198
  • First Published: 27 July 2011

Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems

Lisa J. Herrinton,  Jeffrey R. Curtis,  Lang Chen,  Liyan Liu,  Elizabeth Delzell,  James D. Lewis,  Daniel H. Solomon,  Marie R. Griffin,  Rita Ouellet-Hellstom,  Timothy Beukelman,  Carlos G. Grijalva,  Kevin Haynes,  Bindee Kuriya,  Joyce Lii,  Ed Mitchel,  Nivedita Patkar,  Jeremy Rassen,  Kevin L. Winthrop,  Parivash Nourjah,  Kenneth G. Saag, 
  • Pages: 1199-1209
  • First Published: 15 September 2011

Drug certainty-response in interview-based studies

Wai-Ping Yau,  Kueiyu Joshua Lin,  Martha M. Werler,  Carol Louik,  Allen A. Mitchell,  Sonia Hernández-Díaz, 
  • Pages: 1210-1216
  • First Published: 13 September 2011

Evaluation of the representativeness of a Dutch non-malformed control group for the general pregnant population: are these controls useful for EUROCAT?

Janneke Jentink,  A. Priscilla Zetstra-van der Woude,  Jens Bos,  Lolkje T. W. de Jong-van den Berg, 
  • Pages: 1217-1223
  • First Published: 26 September 2011